Skip to main content
Clinical Trials/CTRI/2019/08/020978
CTRI/2019/08/020978
Completed
Phase 2

A Randomized controlled Parallel two arm study to evaluate the effect of Kinshuktwagadi ghan vati and Darvyadi ghanavati in the management of Prameha WSR to Prediabetes .

RP Ayurved Hospital and Research Centre0 sites140 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
RP Ayurved Hospital and Research Centre
Enrollment
140
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
June 7, 2021
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
RP Ayurved Hospital and Research Centre

Eligibility Criteria

Inclusion Criteria

  • Patients between age 18\-60 yrs; irrespective of sex and socioeconomic status will be selected for the study.
  • 2\. Newly diagnosed cases of hyperglycaemia with lakshanas of Prameha like Prabhut mootrata, Trishna, Kshudhadhikya, Dourbalya, Dantadinammaladhyatvam, Atinidra with Madhumeha Assessment Tool (As mentioned in case paper) Score more than 10 and patients those having Blood Sugar level fasting 100 to 125, Postprandial Blood sugar level more than 140 and less than 200 and HbA1C 5\.7 to 6\.4 % will be selected for the study.

Exclusion Criteria

  • 1\. Type 2 Diabetes Patients, Juvenile Diabetes, Pregnancy induced Diabetes Mellitus patients will be excluded from study.
  • 2\. Diabetes produced due to other illness like acromegaly, cushing Syndrome, pancreatic disorders will be excluded from study.
  • 3\. Patients Suffering from Diabetic Complications like Neuropathy, Retinopathy, Nephropathy, keto acidosis, Gangrene will be excluded from study.
  • 4\. Immune deficiency patient, chronic major illness will be also excluded from study.

Outcomes

Primary Outcomes

Not specified

Similar Trials